Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia
Mutations of ASXL1, encoding a component of the BAP1 histone H2A deubiquitinase
complex, occur in human myeloid neoplasms and are uniformly associated with poor …
complex, occur in human myeloid neoplasms and are uniformly associated with poor …
MLL3/MLL4/COMPASS family on epigenetic regulation of enhancer function and cancer
CC Sze, A Shilatifard - Cold Spring …, 2016 - perspectivesinmedicine.cshlp.org
During development, precise spatiotemporal patterns of gene expression are coordinately
controlled by cis-regulatory modules known as enhancers. Their crucial role in development …
controlled by cis-regulatory modules known as enhancers. Their crucial role in development …
[HTML][HTML] The JAK/STAT pathway in skeletal muscle pathophysiology
V Moresi, S Adamo, L Berghella - Frontiers in physiology, 2019 - frontiersin.org
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is a
key intracellular mediator of a variety of metabolically relevant hormones and cytokines …
key intracellular mediator of a variety of metabolically relevant hormones and cytokines …
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL
C Laurent, A Nicolae, C Laurent… - Blood, The Journal …, 2020 - ashpublications.org
The oncogenic events involved in breast implant–associated anaplastic large cell lymphoma
(BI-ALCL) remain elusive. To clarify this point, we have characterized the genomic …
(BI-ALCL) remain elusive. To clarify this point, we have characterized the genomic …
[HTML][HTML] Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4
Abnormalities in epigenetic modifiers are emerging as driving events in prostate cancer
(PCa). The histone methyltransferase KMT2D, a frequently aberrant epigenetic modifier in …
(PCa). The histone methyltransferase KMT2D, a frequently aberrant epigenetic modifier in …
[HTML][HTML] Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle …
Y Xu, H Zeng, K Jin, Z Liu, Y Zhu, L Xu… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Tumor-associated macrophages (TAMs) secreting IL-10 could be a specific
functional cell subset with distinct polarization state and suppressive role in antitumor …
functional cell subset with distinct polarization state and suppressive role in antitumor …
[HTML][HTML] Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies
Z Wang, P Wang, Y Li, H Peng, Y Zhu… - … and Targeted Therapy, 2021 - nature.com
Hematopoiesis requires finely tuned regulation of gene expression at each stage of
development. The regulation of gene transcription involves not only individual transcription …
development. The regulation of gene transcription involves not only individual transcription …
[HTML][HTML] Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
S Araf, J Wang, K Korfi, C Pangault, E Kotsiou… - Leukemia, 2018 - nature.com
Follicular lymphoma (FL) is an incurable B-cell malignancy characterized by advanced
stage disease and a heterogeneous clinical course, with high-risk groups including those …
stage disease and a heterogeneous clinical course, with high-risk groups including those …
Molecular subgroups of intrahepatic cholangiocarcinoma discovered by single-cell RNA sequencing–assisted multiomics analysis
X Bao, Q Li, J Chen, D Chen, C Ye, X Dai… - Cancer Immunology …, 2022 - AACR
Intrahepatic cholangiocarcinoma (ICC) is a relatively rare but highly aggressive tumor type
that responds poorly to chemotherapy and immunotherapy. Comprehensive molecular …
that responds poorly to chemotherapy and immunotherapy. Comprehensive molecular …
Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer
The incidence of liver cancer has increased in recent years. Worldwide, liver cancer is
common: more than 600000 related deaths are estimated each year. In the USA, about …
common: more than 600000 related deaths are estimated each year. In the USA, about …